loader
Please Wait
Applying Filters...

Seqens Seqens

X

Alnylam Pharmaceuticals's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 GIVOSIRAN SODIUM (1)

02 LUMASIRAN SODIUM (1)

03 PATISIRAN SODIUM (1)

04 VUTRISIRAN SODIUM (1)

filter

01 ALNYLAM PHARMS INC (4)

filter

01 SOLUTION;INTRAVENOUS (1)

02 SOLUTION;SUBCUTANEOUS (3)

filter

01 EQ 10MG BASE/5ML (EQ 2MG BASE/ML) (1)

02 EQ 189MG BASE/ML (EQ 189MG BASE/ML) (1)

03 EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) (1)

04 EQ 94.5MG BASE/0.5ML (EQ 94.5MG BASE/0.5ML) (1)

filter

01 USA (4)

URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 189MG BASE/ML (EQ 1...
GIVLAARI
USA
212194
2019-11-20
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 94.5MG BASE/0.5ML (...
OXLUMO
USA
214103
2020-11-23
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;INTRAVENOUS
EQ 10MG BASE/5ML (EQ 2...
ONPATTRO
USA
210922
2018-08-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 25MG BASE/0.5ML (EQ...
AMVUTTRA
USA
215515
2022-06-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY